Navigation Links
Hepatitis C Virus Market Will Expand Dramatically From $2 Billion in 2008 to Nearly $7.7 Billion in 2013
Date:6/22/2009

Roche and Schering-Plough Will Continue to be Prominent Players in the Market, According to a New Report from Decision Resources

WALTHAM, Mass., June 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the hepatitis C virus drug market will expand dramatically from $2 billion in 2008 to nearly $7.7 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. However, market growth thereafter will decrease to $3.4 billion in 2018 owing to a decline in the prevalence of the disease and the high efficacy of new treatment regimens.

The new Pharmacor report entitled Hepatitis C Virus finds that, through 2013, robust market growth will be driven by the launches of novel hepatitis C virus-specific agents and an increase in the size of the drug-treated population. Roche and Schering-Plough will continue to be prominent players and a number of other companies -- including Johnson & Johnson and Pfizer -- will also carve out a share in the market.

The report also finds that the competitive hepatitis C virus pipeline is characterized by its significant commercial potential which is well-recognized by drug developers. Several agents in late-stage development -- most notably protease inhibitors such as Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Schering-Plough's boceprevir as well as polymerase inhibitors such as Roche/Pharmasset's R-7128 and Pfizer's filibuvir -- will drive market growth.

"The standard of care will change significantly with the introduction of new classes of hepatitis C virus-specific antiviral agents, such as protease inhibitors and polymerase inhibitors," said Decision Resources Analyst Alexandra Makarova, M.D., Ph.D. "Compounds from these new classes will initially be added to the backbone of currently used agents, formin
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Good news for some hard-to-treat hepatitis C patients
2. Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
3. Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients
4. NEJM study points to new era in hepatitis C treatment
5. Resource for Those Living with Hepatitis C Announces Website Redesign
6. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
7. New treatment option for patients with chronic hepatitis C
8. National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action
9. National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action
10. World Health Assembly Forced to Postpone Decision on Viral Hepatitis
11. ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Hills, CA (PRWEB) , ... August 04, 2015 ... ... personal consultation complete with full examination now offered by the world renowned ... more beautiful aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve ...
(Date:8/4/2015)... ... August 04, 2015 , ... Providigm, LLC, ... care facilities, today announced details of the Advanced level of their national accreditation ... Providigm’s QAPI Accreditation program , introduced in 2013, is based on standards ...
(Date:8/4/2015)... D.C. (PRWEB) , ... August ... ... that its HealthCenter personal health record (PHR) product has achieved Office of ... and Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... and Scale-up Online Seminar featuring researchers from Lubrizol, Pfizer, and Merck. ... PM EDT. , Process development project timelines often require informed decisions with limited ...
(Date:8/4/2015)... ... ... The results of a three year clinical trial for the Argus II, ... causes blindness, were published on June 23, 2015 in Ophthalmology , the journal ... implant, more commonly known as the “bionic eye,” is safe and effective for long-term ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2
... A small study suggests that adults whose parents are ... have lower average levels of the stress hormone cortisol ... to a report in the September issue of Archives ... Biological differences seen in individuals with PTSD, including low ...
... nonprofit patient advocacy group, today released updated resources,to help ... back to,school. The organization offers a free fact sheet ... and deliver to their child,s school,teacher; and it offers ... how to treat psoriasis in children and how to ...
... , , MONDAY, Sept. 3 (HealthDay News) --The more hours adults ... job, the less time they spend sleeping. , That,s the ... on slumber. , Adults who sleep four-and-a-half hours or fewer ... 118 minutes more on weekends than the average sleeper, a ...
... LES ULIS, France, September 3 - QUANTEL ... in View,of Acquiring the Company WaveLight Aesthetic GmbH ... the German company WaveLight AG, is,specialized in Dermatology/Aesthetic lasers. ... its revenues are estimated of approx. 10MEUR,for the fiscal ...
... Cambridge, famous as a haunt of students in their ... next generation of antibiotics, according to scientists speaking today ... Microbiologys 161st Meeting at the University of Edinburgh, UK, ... now over-prescribed for treatments of bacterial infections, and patients ...
... Lexington, KY (Aug. 31, 2007) Two worldwide studies published ... growth rate of chronic obstructive pulmonary disease (COPD). The only ... Study was located in Eastern Kentucky, and was found to ... world. In fact, it had the second highest rate ...
Cached Medicine News:Health News:Adult offspring of parents with PTSD have lower cortisol levels 2Health News:Psoriasis Cure Now offers 'Back to School' Resources for Parents of Children with Psoriasis 2Health News:Work Time Predicts Sleep Time 2Health News:QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH 2Health News:New viruses to treat bacterial diseases -- 'My enemies' enemy is my friend' 2Health News:Two studies published in the Lancet 2
(Date:8/4/2015)... PITTSBURGH , Aug. 4, 2015  The Pittsburgh ... sciences investment firm, announced today that one of its ... to sell their Flex ® Robotic System in ... pleased or more proud of Medrobotics," said John ... have come a very long way since spinning out ...
(Date:8/4/2015)...  Sutro Biopharma today announced that it has ... president of alliance and project management. Dr. Vasquez ... of Sutro,s collaborative partnerships and the development of ... antibodies and antibody-based therapeutics targeting immuno-oncology pathways. ... of experience in the biopharmaceutical sector with expertise ...
(Date:8/4/2015)... Aug. 4, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Transdermal ... to their offering. ... - an approach used to deliver drugs ... an alternative to oral,intravascular, subcutaneous and transmucosal ...
Breaking Medicine Technology:Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... 350+ Targeted Drugs on the Market and, in Clinical Development ... Resistance, Enhance Anticancer Effects, and Expand the Markets for ... ... 19 Identification of novel,cancer-related targets and pathways is redefining our ...
... 19 Compendia Bioscience, Inc.,today announced results of ... commitment from all major customers and the addition ... customer roster. The new,customers and existing customer commitment ... with similar growth forecasted for 2008., (Logo: ...
Cached Medicine Technology:Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 2Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 3Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 4On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3
Mid-level interpretive resting ECG...
... The ECG-9010 meets IEC60601-2-51 new international ... and digital filter performance. ECG data ... a Windows PC with the optional ... changed for operating in other countries, ...
The Sonic WAVE™is the first market-ready Alternative to Ultrasound...
... is an innovative, stat analyzer that measures ... on-board co-oximetry and integrated data management "all ... include pH, PCO 2 , PO 2 ... sodium, potassium, chloride, ionized calcium, ionized magnesium, ...
Medicine Products: